Early Day Motion·EDM 1096
Medical Treatment of Kidney Patients
12 June 199069 Signatures
Motion Text
That this House notes that the drug Erythropoietin, EPO, that can greatly improve the lives of kidney patients may be denied to some of them because of financial pressures in the area in which they happen to live; and calls upon the Government to make a thorough assessment of the benefits of the drug and, if appropriate, to ensure that it is equally available to all kidney patients who would benefit from its use.